Dataset
Naringenin; LC-ESI-QTOF; MS2; [M+H]+; CE: 10eV
Chemical Information
| InChI | InChI=1S/C15H12O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-6,13,16-18H,7H2/t13-/m0/s1 |
|---|---|
| SMILES | Oc(c3)ccc(c3)[C@H](C1)Oc(c2)c(c(O)cc(O)2)C(=O)1 |
| InChI Key | FTVWIRXFELQLPI-ZDUSSCGKSA-N |
| Molecular Formula | C15H12O5 |
| Exact Mass | 272.068 g/mol |
Data and Resources
Metadata Information
| Field | Value |
|---|---|
| DOI | |
| License URL | https://creativecommons.org/licenses/by-nc/4.0 |
| Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Fiocruz-FIO00205 |
| Version | |
| Author | |
| Maintainer | |
| Language | |
| MetadataPublished | 2016-01-19 |
| Related Molecule |
|
| Field | Value |
|---|---|
| Measurement Technique | liquid chromatography-mass spectrometry |
| Measurement Variables |
| Data-Source Molecule ID | Data-Source |
|---|---|
| 439246 | PubChem |
| 60021691 | NMRShiftDB |
| PD001602 | ProbesDrugs |
| 16584015 | PubChem: Thomson Pharma |
| 480-41-1 | ACToR |
| Naringenin | Selleck |
| HN5425SBF2 | FDA SRS |
| 1016027 | eMolecules |
| 2699 | Brenda |
| 103754 | Brenda |
| 586 | Brenda |
| 56282 | Brenda |
| 163690 | Brenda |
| MTBLC17846 | Metabolights |
| 128092 | Brenda |
| HMDB0002670 | Human Metabolome Database |
| 17846 | Rhea |
| LSM-45876 | LINCS |
| PA151958361 | PharmGKB |
| 75681 | Brenda |
| SCHEMBL20570 | SureChEMBL |
| DB03467 | DrugBank |
| C00509 | KEGG Ligand |
| CHEMBL9352 | ChEMBL |
| NAR | PDBe |
| 17846 | ChEBI |
| 12015491 | PubChem: Drugs of the Future |
| ZINC000000156701 | ZINC |
| J325.849A | Nikkaji |
| LMPK12140001 | LipidMaps |
| DTXSID1022392 | EPA CompTox Dashboard |
| 23419 | BindingDB |
| HY-N0100 | MedChemExpress |
| NARINGENIN | rxnorm |
| AYUJAH | CCDC |
| The data in this table is sourced from UniChem at EBI. | |